Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,048
Closed -$304K 4089
2025
Q4
$304K Sell
10,048
-59,489
-86% -$1.46M ﹤0.01% 3802
2025
Q3
$1.38M Sell
69,537
-145,218
-68% -$3.04M ﹤0.01% 3199
2025
Q2
$5.35M Buy
214,755
+22,777
+12% +$513K ﹤0.01% 2309
2025
Q1
$4.5M Buy
191,978
+31,390
+20% +$909K ﹤0.01% 2390
2024
Q4
$4.49M Buy
160,588
+6,365
+4% +$171K ﹤0.01% 2432
2024
Q3
$3.14M Sell
154,223
-9,760
-6% -$219K ﹤0.01% 2679
2024
Q2
$4.84M Buy
163,983
+3,989
+2% +$115K ﹤0.01% 2343
2024
Q1
$4.88M Buy
159,994
+8,780
+6% +$248K ﹤0.01% 2392
2023
Q4
$3.54M Buy
151,214
+7,598
+5% +$184K ﹤0.01% 2579
2023
Q3
$4.25M Buy
143,616
+7,955
+6% +$267K ﹤0.01% 2408
2023
Q2
$4.79M Sell
135,661
-5,281
-4% -$148K ﹤0.01% 2371
2023
Q1
$3.39M Buy
140,942
+6,069
+4% +$141K ﹤0.01% 2570
2022
Q4
$3M Buy
134,873
+39,883
+42% +$924K ﹤0.01% 2609
2022
Q3
$2.26M Buy
94,990
+30,792
+48% +$830K ﹤0.01% 2734
2022
Q2
$1.49M Buy
+64,198
New +$1.73M ﹤0.01% 2939
2021
Q3
Sell
-93,614
Closed -$4.45M 3872
2021
Q2
$4.45M Buy
+93,614
New +$4.53M ﹤0.01% 2536

Other funds holding CFLT

Ameriprise's CFLT Position: Q1 2026 in Review

Ameriprise sold out of Confluent (CFLT) in Q1 2026, closing a stake of 10,048 shares — an estimated $304K sold.

Ameriprise first reported a position in CFLT in Q2 2021 and held it in 16 quarters. The position peaked at $5.35M in Q2 2025. 4 funds tracked by Wall St. Rank hold CFLT as of Q1 2026.

  • Ameriprise reported no remaining Confluent position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 10,048 Confluent shares in Q1 2026, an estimated $304K.
  • Ameriprise first reported a position in Confluent in Q2 2021 and held it in 16 quarters.
  • Ameriprise's Confluent position peaked at $5.35M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Confluent as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.